These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20003606)

  • 1. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
    J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
    Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
    Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):505-14. PubMed ID: 15373864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
    Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
    Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of vestibular schwannomas: third review of a 10-year prospective study.
    Hajioff D; Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol; 2008 Jun; 33(3):255-9. PubMed ID: 18559034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vestibular schwannoma. A new interpretation of tumor growth].
    Charabi S; Tos M; Thomsen JC; Charabi BW; Mantoni MY
    Ugeskr Laeger; 2000 Oct; 162(41):5497-500. PubMed ID: 11068526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve origin of vestibular schwannoma: a prospective study.
    Khrais T; Romano G; Sanna M
    J Laryngol Otol; 2008 Feb; 122(2):128-31. PubMed ID: 18039415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid enlargement of a vestibular schwannoma following gamma knife treatment.
    McEvoy AW; Kitchen ND
    Minim Invasive Neurosurg; 2003 Aug; 46(4):254-6. PubMed ID: 14506573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
    Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
    Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large vestibular schwannoma that did not grow for 18 years.
    Timmer FC; Graamans K
    B-ENT; 2011; 7(4):305-7. PubMed ID: 22338247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of vestibular schwannoma.
    Stangerup SE; Caye-Thomasen P; Tos M; Thomsen J
    Otol Neurotol; 2006 Jun; 27(4):547-52. PubMed ID: 16791048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of vestibular schwannomas of 15 to 31 mm intracranial diameter.
    Reddy CE; Lewis-Jones HG; Javadpour M; Ryland I; Lesser TH
    J Laryngol Otol; 2014 Sep; 128(9):752-8. PubMed ID: 25120176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative management of sporadic unilateral acoustic neuromas.
    Flint D; Fagan P; Panarese A
    J Laryngol Otol; 2005 Jun; 119(6):424-8. PubMed ID: 15992466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of acoustic neuromas.
    Rosenberg SI
    Laryngoscope; 2000 Apr; 110(4):497-508. PubMed ID: 10763994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic unilateral vestibular schwannoma in the pediatric population. Clinical article.
    Walcott BP; Sivarajan G; Bashinskaya B; Anderson DE; Leonetti JP; Origitano TC
    J Neurosurg Pediatr; 2009 Aug; 4(2):125-9. PubMed ID: 19645545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2.
    Li H; Hao SY; Wang L; Li D; Wu Z; Zhang LW; Zhang JT
    Acta Neurochir (Wien); 2015 Nov; 157(11):1983-90. PubMed ID: 26287269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of vestibular schwannoma.
    González-Orús Álvarez-Morujo RJ; Alvarez-Palacios I; Martin-Oviedo C; Scola-Yurrita B; Arístegui-Ruiz MÁ
    Acta Otorrinolaringol Esp; 2014; 65(5):275-82. PubMed ID: 24930856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.